CHICAGO (AP) _ Xeris Biopharma Holdings, Inc. (XERS) on Wednesday reported a loss of $26 million in its third quarter.

The Chicago-based company said it had a loss of 39 cents per share. Losses, adjusted for non-recurring costs, came to 36 cents per share.

The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 37 cents per share.

The company posted revenue of $11 million in the period, also exceeding Street forecasts. Three analysts surveyed by Zacks expected $10.4 million.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XERS at https://www.zacks.com/ap/XERS

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News